_id
6919e67e3c536f8df231818e
Ticker
CRTX.LSE
Name
Amur Minerals Corporation
Exchange
LSE
Address
Kingston Chambers, Road Town, British Virgin Islands
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.crismtherapeutics.com
Description
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Last Close
95000
Volume
156456
Current Price
10.05
Change
0
Last Updated
2025-12-29T15:12:05.968Z
Image
https://logo.clearbit.com/www.crismtherapeutics.com
Ipo Date
-
Market Cap
4914850
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
4117
Gross Profit
-4117
Operating Expenses
1242176
Operating Income
-1246294
Interest Expense
-
Pretax Income
-1246294
Net Income
-1276490
Eps
-0.03906249282777636
Dividends Per Share
-
Shares Outstanding
51735266
Income Tax Expense
-
EBITDA
-1235313
Operating Margin
-
Total Other Income Expense Net
-
Cash
479027
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2127484
Property Plant Equipment
60393
Total Assets
2381409
Payables
144119
Short Term Debt
-
Long Term Debt
-
Total Liabilities
583342
Equity
1798067
Bs_currency_symbol
-
Depreciation
10980
Change In Working Capital
-42549
Cash From Operations
-1192763
Capital Expenditures
0
Cash From Investing
-91962
Cash From Financing
-
Net Change In Cash
479027
Cf_currency_symbol
-
PE
-
PB
182.6491490584055
ROE
-70.99234900590467
ROA
-53.60230015087707
FCF
-1192763
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
4117
Quarters > 0 > income Statement > gross Profit
-4117
Quarters > 0 > income Statement > operating Expenses
1242176
Quarters > 0 > income Statement > operating Income
-1246294
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1246294
Quarters > 0 > income Statement > net Income
-1276490
Quarters > 0 > income Statement > eps
-0.03906249282777636
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
32678150
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1235313
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
479027
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2127484
Quarters > 0 > balance Sheet > property Plant Equipment
60393
Quarters > 0 > balance Sheet > total Assets
2381409
Quarters > 0 > balance Sheet > payables
144119
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
583342
Quarters > 0 > balance Sheet > equity
1798067
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1276490
Quarters > 0 > cash Flow > depreciation
10980
Quarters > 0 > cash Flow > change In Working Capital
-42549
Quarters > 0 > cash Flow > cash From Operations
-1192763
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-91962
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
479027
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.03906249282777636
Quarters > 0 > ratios > PB
182.6491490584055
Quarters > 0 > ratios > ROE
-70.99234900590467
Quarters > 0 > ratios > ROA
-53.60230015087707
Quarters > 0 > ratios > FCF
-1192763
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
20251
Quarters > 1 > income Statement > gross Profit
-20251.2
Quarters > 1 > income Statement > operating Expenses
2531.4
Quarters > 1 > income Statement > operating Income
-2531.4
Quarters > 1 > income Statement > interest Expense
27844
Quarters > 1 > income Statement > pretax Income
-16454.1
Quarters > 1 > income Statement > net Income
-16454.1
Quarters > 1 > income Statement > eps
-0.002708261563082409
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6075521
Quarters > 1 > income Statement > income Tax Expense
-20.66
Quarters > 1 > income Statement > EBITDA
6113
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-13922
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2353774
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2909982
Quarters > 1 > balance Sheet > property Plant Equipment
75846
Quarters > 1 > balance Sheet > total Assets
3060411
Quarters > 1 > balance Sheet > payables
190880
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
443702
Quarters > 1 > balance Sheet > equity
2616709
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-32908.2
Quarters > 1 > cash Flow > depreciation
10125
Quarters > 1 > cash Flow > change In Working Capital
-526531.2
Quarters > 1 > cash Flow > cash From Operations
-592347.6
Quarters > 1 > cash Flow > capital Expenditures
8859.9
Quarters > 1 > cash Flow > cash From Investing
2973128
Quarters > 1 > cash Flow > cash From Financing
129100
Quarters > 1 > cash Flow > net Change In Cash
2353774
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.002708261563082409
Quarters > 1 > ratios > PB
23.33426684052373
Quarters > 1 > ratios > ROE
-0.6288089351930229
Quarters > 1 > ratios > ROA
-0.537643473376615
Quarters > 1 > ratios > FCF
-601207.5
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1255.1
Quarters > 2 > income Statement > operating Income
-1255.1
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-8158.15
Quarters > 2 > income Statement > net Income
-8158.15
Quarters > 2 > income Statement > eps
-0.0013427901903392317
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6075521
Quarters > 2 > income Statement > income Tax Expense
-187009.9
Quarters > 2 > income Statement > EBITDA
-183244.6
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-6903.05
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-8158.15
Quarters > 2 > cash Flow > depreciation
5020.4
Quarters > 2 > cash Flow > change In Working Capital
-261060.8
Quarters > 2 > cash Flow > cash From Operations
-293693.4
Quarters > 2 > cash Flow > capital Expenditures
4392.85
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
64010.1
Quarters > 2 > cash Flow > net Change In Cash
1167870.55
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0013427901903392317
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-298086.25
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
292543
Quarters > 3 > income Statement > operating Income
-292540
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-425701
Quarters > 3 > income Statement > net Income
-422000
Quarters > 3 > income Statement > eps
-0.04843240265460065
Quarters > 3 > income Statement > dividends Per Share
2154000
Quarters > 3 > income Statement > shares Outstanding
8713175
Quarters > 3 > income Statement > income Tax Expense
-56268.5
Quarters > 3 > income Statement > EBITDA
-292540
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-133161
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
4384000
Quarters > 3 > balance Sheet > short Term Investments
945030
Quarters > 3 > balance Sheet > receivables
315343
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4786000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
4786000
Quarters > 3 > balance Sheet > payables
471000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
662000
Quarters > 3 > balance Sheet > equity
4124000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-418
Quarters > 3 > cash Flow > depreciation
-976
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-641000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
931000
Quarters > 3 > cash Flow > cash From Financing
-2154000
Quarters > 3 > cash Flow > net Change In Cash
-1930640
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.04843240265460065
Quarters > 3 > ratios > PB
21.233610269156163
Quarters > 3 > ratios > ROE
-10.23278370514064
Quarters > 3 > ratios > ROA
-8.817384036773925
Quarters > 3 > ratios > FCF
-641000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
25000
Annuals > 0 > income Statement > cost Of Revenue
4000
Annuals > 0 > income Statement > gross Profit
21000
Annuals > 0 > income Statement > operating Expenses
603000
Annuals > 0 > income Statement > operating Income
-582000
Annuals > 0 > income Statement > interest Expense
11000
Annuals > 0 > income Statement > pretax Income
-593000
Annuals > 0 > income Statement > net Income
-607000
Annuals > 0 > income Statement > eps
-0.09990912713494036
Annuals > 0 > income Statement > dividends Per Share
47000
Annuals > 0 > income Statement > shares Outstanding
6075521
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-566000
Annuals > 0 > income Statement > operating Margin
-2328
Annuals > 0 > income Statement > total Other Income Expense Net
-11000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1282000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1690000
Annuals > 0 > balance Sheet > property Plant Equipment
52000
Annuals > 0 > balance Sheet > total Assets
1816000
Annuals > 0 > balance Sheet > payables
29000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
341000
Annuals > 0 > balance Sheet > equity
1475000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-607000
Annuals > 0 > cash Flow > depreciation
16000
Annuals > 0 > cash Flow > change In Working Capital
-55000
Annuals > 0 > cash Flow > cash From Operations
-933000
Annuals > 0 > cash Flow > capital Expenditures
28000
Annuals > 0 > cash Flow > cash From Investing
2328000
Annuals > 0 > cash Flow > cash From Financing
-67000
Annuals > 0 > cash Flow > net Change In Cash
1281000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.09990912713494036
Annuals > 0 > ratios > PB
38.75976448135593
Annuals > 0 > ratios > ROE
-41.152542372881356
Annuals > 0 > ratios > ROA
-33.42511013215859
Annuals > 0 > ratios > FCF
-961000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-38.44
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
57366
Annuals > 1 > income Statement > cost Of Revenue
40793
Annuals > 1 > income Statement > gross Profit
16572
Annuals > 1 > income Statement > operating Expenses
2259000
Annuals > 1 > income Statement > operating Income
-2259000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-1923491
Annuals > 1 > income Statement > net Income
-9647000
Annuals > 1 > income Statement > eps
-1.1081562574988935
Annuals > 1 > income Statement > dividends Per Share
31447000
Annuals > 1 > income Statement > shares Outstanding
8705451
Annuals > 1 > income Statement > income Tax Expense
203532
Annuals > 1 > income Statement > EBITDA
-2259000
Annuals > 1 > income Statement > operating Margin
-3937.8726074678384
Annuals > 1 > income Statement > total Other Income Expense Net
335509
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
3438970
Annuals > 1 > balance Sheet > short Term Investments
945030
Annuals > 1 > balance Sheet > receivables
15297
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4786000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
4786000
Annuals > 1 > balance Sheet > payables
471000
Annuals > 1 > balance Sheet > short Term Debt
501000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
662000
Annuals > 1 > balance Sheet > equity
4124000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-1923491
Annuals > 1 > cash Flow > depreciation
-175000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-2770000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
34931000
Annuals > 1 > cash Flow > cash From Financing
-31447000
Annuals > 1 > cash Flow > net Change In Cash
760000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-1.1081562574988935
Annuals > 1 > ratios > PB
19.863795807468478
Annuals > 1 > ratios > ROE
-233.92337536372452
Annuals > 1 > ratios > ROA
-201.56707062264937
Annuals > 1 > ratios > FCF
-2770000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-48.28644144615277
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2224000
Annuals > 2 > income Statement > operating Income
-2224000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-2605000
Annuals > 2 > income Statement > net Income
-2446053
Annuals > 2 > income Statement > eps
-0.2812289276890554
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8697729
Annuals > 2 > income Statement > income Tax Expense
331228
Annuals > 2 > income Statement > EBITDA
-1805520
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-381000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
2895502
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2947875
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
23893091
Annuals > 2 > balance Sheet > payables
131000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
765649
Annuals > 2 > balance Sheet > equity
23127442
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-2114825
Annuals > 2 > cash Flow > depreciation
277000
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-3515000
Annuals > 2 > cash Flow > capital Expenditures
265469
Annuals > 2 > cash Flow > cash From Investing
-511000
Annuals > 2 > cash Flow > cash From Financing
968000
Annuals > 2 > cash Flow > net Change In Cash
-3058000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.2812289276890554
Annuals > 2 > ratios > PB
3.538896774230371
Annuals > 2 > ratios > ROE
-10.576409617630866
Annuals > 2 > ratios > ROA
-10.237490829461956
Annuals > 2 > ratios > FCF
-3780469
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
38
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1300076
Annuals > 3 > income Statement > operating Income
-1300080
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-1301530
Annuals > 3 > income Statement > net Income
-1542204
Annuals > 3 > income Statement > eps
-0.17882282660155996
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8624201
Annuals > 3 > income Statement > income Tax Expense
240674
Annuals > 3 > income Statement > EBITDA
-1300080
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1450
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
4933367
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
17925
Annuals > 3 > balance Sheet > inventories
2
Annuals > 3 > balance Sheet > total Current Assets
5013843
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
23063235
Annuals > 3 > balance Sheet > payables
101000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
832072
Annuals > 3 > balance Sheet > equity
30111000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-1301530
Annuals > 3 > cash Flow > depreciation
277000
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1833000
Annuals > 3 > cash Flow > capital Expenditures
309749
Annuals > 3 > cash Flow > cash From Investing
6038000
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
3892000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.17882282660155996
Annuals > 3 > ratios > PB
2.6951523167613165
Annuals > 3 > ratios > ROE
-5.121729600478231
Annuals > 3 > ratios > ROA
-6.686850305258564
Annuals > 3 > ratios > FCF
-2142749
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
43
Valuation > metrics > PE
-0.03906249282777636
Valuation > metrics > PB
182.6491490584055
Valuation > final Score
20
Valuation > verdict
5988.3% Overvalued
Profitability > metrics > ROE
-70.99234900590467
Profitability > metrics > ROA
-59.999981198448495
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3244272877484543
Risk > metrics > Interest Coverage
-113.49549221382388
Risk > final Score
-394
Risk > verdict
High
Liquidity > metrics > Current Ratio
14.761995295554367
Liquidity > metrics > Quick Ratio
14.761995295554367
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
50
Prev Profitabilities > 2
15
Prev Risks > 0
60
Prev Risks > 1
30
Prev Risks > 2
51
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T23:00:50.524Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-15
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.03
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.03
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-09-19
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Amur Minerals Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.03
EPS Estimate
0
EPS Difference
-0.03
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.